Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Northern Bear, Airsprung, Pursuit Dynamics...

Tue, 29th Jun 2010 11:03

Support services group Northern Bear stretched its strong run Tuesday after claiming a good start to the new financial year, with its order book and pipeline well up on a year ago."The board is pleased to announce that the new financial year has started well, with strong order books and a healthy pipeline, both far exceeding the outlook at the corresponding time last year," the firm said in a brief statement. Results for the year ended 31 March will be published on 7 July.Mattress and sofa company Airsprung Group has warned that first half profits will be "modestly" below last year's effort as the general election campaign dampened consumer enthusiasm.Revenue for the two months since April is also down on last year as January's snow storms left retailers with lots of stock leftover, leaving them unable to re order at the normal levels for spring business.The company, which today dropped the 'Furniture' from its name, is also wary about "challenging" economic conditions despite turning a £417,000 loss into a £978,000 profit for the year to 31 March. Full-year sales grew 9% to £46.5m.Pursuit Dynamics, a maker of pump technology for brewers, food manufacturers and fire extinguishers, has formally launched its new bio-fuels line of business with a suite of products designed to make substantial cost savings for customers and improve productivity.Losses grew to £3.66m for the year to March from £3.09m in 2009. The firm had cash of £3.7m at the period end following a £4m fundraising in September. A placing last month brought in another £10m.Drug discovery outfit e-Therapeutics was "delighted" with progress during the year to 31 January and says it's in talks with a number of drug companies to develop its own drug portfolio and deploy its de-risking technology commercially.In a year that saw the group raise a total of £4.5m, the company lost £1.78m, a little more than the £1.55m deficit published the year before.Seismic surveyor Offshore Hydrocarbon Mapping slipped as it warned scheduling delays had increased costs and will put pressure on working capital later in the summer, potentially requiring new capital to be raised.Revenues and operating losses for the six months to August will be in the range of £6.6m to £7.1m and £2.8m to £3.3m respectively, which compares to £3m and £1.8m for the same period in 2009. African Diamonds shares fell as it received a revised feasibility study on its jointly owned Boteti Mining AK6 project in Botswana that recommends upfront capital investment of $120m. Operating costs over the life of mine are estimated to be $17.20 per tonne of ore treated.The revised mining plan calls for a smaller number of carats being produced at a higher diamond value. A process plant designed at an initial throughput rate of 2.5m tonnes per annum increasing to 4.0mtpa after 4 years is suggested.Malaysia-focused mobile payments group MobilityOne lifted revenue by 10.2% to £13.7m in 2009. Losses after tax rose slightly to £920,000. New agreements have been signed with Carrefour Malaysia and Telekom Malaysia in Malaysia, several telecommunications companies in Cambodia and PT Citra Multi Services in Indonesia and barring any unforeseen circumstances, the group is anticipating an upturn in the 4th quarter of 2010.Specialist filtration and environmental technology group Porvair expects to maintain its strategic progress in the second half of the year after a strong showing at the interim stage.In the six months to the end of May the company's pre-tax profit was £1.28m, versus a profit (excluding exceptional items) of £0.04m the year before.Revenue grew to £29.66m from £27.00m previously, with 23% of revenues attributable to what the company terms "next generation" products.The interim dividend has been maintained at 1p.Travelgroup Travelzest more than doubled profits at the halfway stage as the benefits of its restructuring programme started feeding through.Profit before tax in the six months to 30 April surged to £1.4m from £0.6m at the interim stage the year before. Total transaction valued jumped 14% to £118.7m from £104m a year earlier while revenue increased 9% to £18.9m from £17.4m.Net debt came down to £7.7m at the end of the reporting period from £11.7m at the end of April 2009. The group said it remains on the look out for acquisition opportunities.British Polythene expects half year results to be slightly lower than 2009 equivalents due to increased polymer prices. "Trading across the board continues to be challenging as we, and our customers, address the impact of these polymer price increases. Polymer prices have started to ease in North America and the Far East, but remain obstinately firm in Western Europe," said the group.Alternative energy firm Cosalt was lower after it saw sales fall to £48.3m from £52.8m, reflecting current caution across the UK Oil & Gas sector. Profits before exceptionals were doubled to £1m due to lower financing costs.Timber merchant James (Latham) saw profits rise to £5.58m from £4.11m. Revenue rose 1.3% to £113m after being 5.9% behind at six months. Shares in Ceramic Fuel Cells rose after it entered a licence agreement with USA-based NexTech Materials. NexTech will commercially offer solid oxide fuel cell interconnect coating solutions based on Ceramic Fuel Cells' patented formulations.
More News
8 May 2014 10:51

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui

Read more
7 Apr 2014 12:25

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl

Read more
7 Apr 2014 10:57

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com

Read more
31 Mar 2014 12:50

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Fluo

Read more
31 Mar 2014 12:45

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Flou

Read more
31 Mar 2014 10:35

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Babcock International Group, up 3.5%. The company said its Cavendish Fluor Partnership has

Read more
31 Mar 2014 08:33

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed

Read more
26 Mar 2014 13:40

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.<

Read more
26 Mar 2014 11:30

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Standard Life, up 5.2%. The company has agreed to buy Ignis Asset Mana

Read more
26 Mar 2014 11:03

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 11:01

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more
31 Oct 2013 13:36

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.